The brands were acquired following recent mergers and allow Vetoquinol to play an “increasingly important” role in supporting practices with their preventative healthcare programmes.
The company said the return to a “new normal” post-lockdown provides a significant opportunity for practices to apply a renewed focus to preventative healthcare, recommending parasiticides as a way to improve animal welfare but also generate practice revenue, which is vital for economic recovery.
Caitrina Oakes, Vetoquinol managing director UK and Ireland, said she is delighted to have brought the brands into the Vetoquinol portfolio.
She said: “Vetoquinol has long held a reputation for delivering therapeutic products that extend the capability of clinicians to treat and manage disease. Preventative care is also playing an increasingly central role in practices, with the emphasis on helping pets live longer, healthier, happier lives.
“With many pet owners spending more hours than ever with their pets during lockdown, companion animal parasiticides have never been more important – making Profender and Drontal highly relevant in the current environment.”
She added: “It’s a very challenging time for many veterinary practices as everyone adapts to the post-Covid world. I’m looking forward to seeing how the passion and ambition we bring to our brands helps Profender and Drontal to grow and helps us to better serve the needs of the veterinary community, both now and in the future.”